The Path Forward for Infused Biosimilars in the US

In this exclusive PC Podcast interview, Vibhu Tewary, project director, IQVIA Institute for Human Data Science, discusses highlights of the company’s report surrounding the “Long-term Market Sustainability for Infused Biosimilars in the US: Foundational Analytics on Emerging Risks to Sustainability"; the process that constructing and piecing together a report of this magnitude entails, along with where the idea itself came from; the concept of net cost recovery; the ongoing challenges surrounding ASP-based reimbursement; and a closed-door, multi-stakeholder virtual roundtable (based on his original report) that was previously held.